Assessing the impact of COmorbidities and Sociodemographic factors on Multiorgan Injury following COVID-19: rationale and protocol design of COSMIC, a UK multicentre observational study of COVID-negative controls
Introduction SARS-CoV-2 disease (COVID-19) has had an enormous health and economic impact globally. Although primarily a respiratory illness, multi-organ involvement is common in COVID-19, with evidence of vascular-mediated damage in the heart, liver, kidneys and brain in a substantial proportion of...
Saved in:
| Main Authors: | Christopher E Brightling, Kamlesh Khunti, Naveed Sattar, Colin Berry, John P Greenwood, Gerry P McCann, Kelly S Parke, Joanne V Wormleighton, Stefan Neubauer, Betty Raman, Charalambos Antoniades, Elizabeth M Tunnicliffe, Alastair Moss, Jayanth Ranjit Arnold, Mark Toshner, Sue Francis, Sandeep S Hothi, Stephen M Smith, Mohamed Elshibly, Simran Shergill, Rachel J England, George J Hudson, James Wild |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-03-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/15/3/e089508.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Multiorgan tuberculosis
by: Đokić Milomir, et al.
Published: (2002-01-01) -
Etiological and immunopathogenetic aspects of multiorgan failure development in coronavirus disease (COVID-19)
by: T. V. Ashcheulova, et al.
Published: (2024-07-01) -
Long covid: risk factors, outcomes, and future directions for research
by: Kamlesh Khunti, et al.
Published: (2022-12-01) -
Differential association between inflammatory cytokines and multiorgan dysfunction in COVID-19 patients with obesity.
by: Marie-Agnès Dragon-Durey, et al.
Published: (2021-01-01) -
Quantitative multiorgan proteomics of fatal COVID‐19 uncovers tissue‐specific effects beyond inflammation
by: Lisa Schweizer, et al.
Published: (2023-07-01)